新加坡农业生物技术年报(2020)  

Singapore Agricultural Biotechnology Annual(2020)

作　　者：王迪[1] 苗朝华[1] 金芜军(编译)[1] WANG Di;MIAO Chaohua;JIN Wujun(Biotechnology Research Institute,Chinese Academy of Agricultural Sciences,Beijing 100081,China)

机构地区：[1]中国农业科学院生物技术研究所,北京100081

出　　处：《生物技术进展》2021年第6期813-817,共5页Current Biotechnology

摘　　要：目前,新加坡国内还没有任何植物生物技术投入商业化生产。截至2020年10月,新加坡共有43种转基因(genetically engineered,GE)植物产品获准用作食品或食品成分。新加坡遗传改良咨询委员会(Genetic Modification Advisory Committee,GMAC)最近修订了关于基因叠加事件的法规,采用“高覆盖低”的方法,对来源于先前GMAC认可的较低阶组合的高阶叠加事件组合豁免监管评估。Singapore does not have any domestic commercial production of plant biotechnology.As of October 2020,a total of 43 genetically engineered(GE)plant products have been approved for use as food or food ingredients in the country.Singapore’s Genetic Modification Advisory Committee(GMAC)recently revised its regulations on stacked events to adopt the"high covers low"approach which exempts higher order combinations of stacked events from regulatory assessment if they are derived from prior GMAC⁃endorsed lower order combinations.

关 键 词：新加坡 农业生物技术 贸易和生产 政策 营销 

分 类 号：Q789[生物学—分子生物学]